Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02969577 · ClinicalTrials.gov registry record · NA
Staying Strong and Healthy During Androgen Deprivation Therapy (ADT) for Men
A NA study of Prostate Cancer, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 2
- Study locations
NCT02969577: Completed NA study of Prostate Cancer, sponsored by University of Kansas Medical Center.
NCT02969577 is a NA study of Prostate Cancer that has completed, run by University of Kansas Medical Center. The registered enrollment target is 38 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02969577, a NA study of Prostate Cancer, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to learn if lifestyle changes and counseling along with standard medical care, compared to standard medical care alone, can prevent heart problems and diabetes in men who are receiving ADT for prostate cancer treatment.
Conditions Studied
Interventions
- BEHAVIORAL Exercise Program
- BEHAVIORAL Diet and Nutrition Coaching
- OTHER Usual Care with Attention
Study Locations (2)
California
- University of California, Los Angeles - Los Angeles
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2017-03-07 |
| Est. Completion | 2020-07-31 |
| Phase | NA |
What the finished NCT02969577 record still lists
NCT02969577 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 3 interventions - of which Exercise Program is the first listed.
NCT02969577 reports a single indexed study location in California, Kansas.
Frequently Asked Questions
What is clinical trial NCT02969577 about?
NCT02969577 is a clinical study titled "Staying Strong and Healthy During Androgen Deprivation Therapy (ADT) for Men". The purpose of this study is to learn if lifestyle changes and counseling along with standard medical care, compared to standard medical care alone, can prevent heart problems and diabetes in men who are receiving ADT for prostate cancer treatment.
What is the current status of trial NCT02969577?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2017-03-07. Estimated completion is 2020-07-31.
What conditions does trial NCT02969577 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT02969577?
The interventions under investigation include: Exercise Program (BEHAVIORAL), Diet and Nutrition Coaching (BEHAVIORAL), Usual Care with Attention (OTHER).
Who is sponsoring clinical trial NCT02969577?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02969577 being conducted?
This trial has 2 study locations across California, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02969577's enrollment target sits among peer trials
38 538th of 735 higher than 196 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI